Direct oral anticoagulant use in gynecologic oncology: A Society of Gynecologic Oncology Clinical Practice Statement
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Direct oral anticoagulant use in gynecologic oncology: A Society of Gynecologic Oncology Clinical Practice Statement
Authors
Keywords
Venous thromboembolism, Direct oral anticoagulant, DOAC, Thrombosis, Anticoagulation
Journal
GYNECOLOGIC ONCOLOGY
Volume 160, Issue 1, Pages 312-321
Publisher
Elsevier BV
Online
2020-11-28
DOI
10.1016/j.ygyno.2020.11.020
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Incidence of venous thromboembolism among patients receiving neoadjuvant chemotherapy for advanced epithelial ovarian cancer
- (2020) Julia Rose Salinaro et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer
- (2020) Giancarlo Agnelli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of Apixaban vs Enoxaparin for Preventing Postoperative Venous Thromboembolism in Women Undergoing Surgery for Gynecologic Malignant Neoplasm
- (2020) Saketh R. Guntupalli et al. JAMA Network Open
- Predicting VTE in Cancer Patients: Candidate Biomarkers and Risk Assessment Models
- (2019) Silvia Riondino et al. Cancers
- Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors
- (2019) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer
- (2019) Alok A. Khorana et al. NEW ENGLAND JOURNAL OF MEDICINE
- Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant
- (2019) James D. Douketis et al. JAMA Internal Medicine
- Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update Summary
- (2019) Nigel S. Key et al. Journal of Oncology Practice
- Apixaban and dalteparin in active malignancy‐associated venous thromboembolism: The ADAM VTE trial
- (2019) Robert D. McBane et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- 2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer
- (2019) Dominique Farge et al. LANCET ONCOLOGY
- Multivariable clinical-genetic risk model for predicting venous thromboembolic events in patients with cancer
- (2018) Andrés J. Muñoz Martín et al. BRITISH JOURNAL OF CANCER
- Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)
- (2018) Annie M. Young et al. JOURNAL OF CLINICAL ONCOLOGY
- Regional Gastrointestinal Absorption of Apixaban in Healthy Subjects
- (2018) Wonkyung Byon et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Venous thromboembolism in cancer patients receiving neoadjuvant chemotherapy: a systematic review and meta-analysis
- (2018) M. Di Nisio et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Role of direct oral anticoagulants in the treatment of cancer-associated venous thromboembolism: guidance from the SSC of the ISTH
- (2018) A. A. Khorana et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
- (2018) Gary E. Raskob et al. NEW ENGLAND JOURNAL OF MEDICINE
- Direct oral anticoagulant (DOAC) versus low-molecular-weight heparin (LMWH) for treatment of cancer associated thrombosis (CAT): A systematic review and meta-analysis
- (2018) Ang Li et al. THROMBOSIS RESEARCH
- A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts
- (2018) Ingrid Pabinger et al. Lancet Haematology
- NCCN Guidelines Insights: Cancer-Associated Venous Thromboembolic Disease, Version 2.2018
- (2018) Michael B. Streiff et al. Journal of the National Comprehensive Cancer Network
- Apixaban to Prevent Venous Thromboembolism in Patients with Cancer
- (2018) Marc Carrier et al. NEW ENGLAND JOURNAL OF MEDICINE
- Characterization of Risk Factors and Timing of Venous Thromboembolism in Patients With Uterine Serous Carcinoma
- (2018) Gregory M. Gressel et al. OBSTETRICS AND GYNECOLOGY
- Characteristics and Management of Patients with Venous Thromboembolism: The GARFIELD-VTE Registry
- (2018) Sylvia Haas et al. THROMBOSIS AND HAEMOSTASIS
- Prevention of venous thromboembolism in gynecologic oncology surgery
- (2017) Emma L Barber et al. GYNECOLOGIC ONCOLOGY
- Direct oral anti-coagulants compared with vitamin-K inhibitors and low-molecular-weight-heparin for the prevention of venous thromboembolism in patients with cancer: A meta-analysis study
- (2017) Natale Daniele Brunetti et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Venous Thromboembolism in Gynecological Malignancy
- (2017) Abigail Cohen et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Predictors of active cancer thromboembolic outcomes: validation of the Khorana score among patients with lung cancer: comment
- (2017) S. Noble et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Effect of major gastrointestinal tract surgery on the absorption and efficacy of direct acting oral anticoagulants (DOACs)
- (2017) Hakeam A. Hakeam et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Idarucizumab for Dabigatran Reversal — Full Cohort Analysis
- (2017) Charles V. Pollack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Preventing Venous Thromboembolism in Ambulatory Cancer Patients: The ONKOTEV Study
- (2017) Chiara Alessandra Cella et al. ONCOLOGIST
- A Predictive Score for Thrombosis Associated with Breast, Colorectal, Lung, or Ovarian Cancer: The Prospective COMPASS–Cancer‐Associated Thrombosis Study
- (2017) Grigoris T. Gerotziafas et al. ONCOLOGIST
- The Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study for Patients on a Direct Oral Anticoagulant Who Need an Elective Surgery or Procedure: Design and Rationale
- (2017) Alex Spyropoulos et al. THROMBOSIS AND HAEMOSTASIS
- The Khorana score for the prediction of venous thromboembolism in patients with pancreatic cancer
- (2017) N. van Es et al. THROMBOSIS RESEARCH
- Antithrombotic Therapy for VTE Disease
- (2016) Clive Kearon et al. CHEST
- Predictors of active cancer thromboembolic outcomes: validation of the Khorana score among patients with lung cancer
- (2016) A. S. Mansfield et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Perioperative Management of DabigatranCLINICAL PERSPECTIVE
- (2015) Sam Schulman et al. CIRCULATION
- Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer
- (2015) Agnes Y. Y. Lee et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation
- (2015) James D. Douketis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treatment of venous thromboembolism in patients with cancer: A network meta-analysis comparing efficacy and safety of anticoagulants
- (2015) Florian Posch et al. THROMBOSIS RESEARCH
- Efficacy and Safety of Anticoagulant Therapy for the Treatment of Acute Cancer-Associated Thrombosis: A Systematic Review and Meta-Analysis
- (2014) Marc Carrier et al. THROMBOSIS RESEARCH
- Lack of Evidence to Support Thromboprophylaxis in Hospitalized Medical Patients with Cancer
- (2013) Marc Carrier et al. AMERICAN JOURNAL OF MEDICINE
- Perioperative care in gynecologic oncology
- (2013) Christina L. Kushnir et al. CURRENT OPINION IN OBSTETRICS & GYNECOLOGY
- Venous Thromboembolism Risk in Patients With Cancer Receiving Chemotherapy: A Real-World Analysis
- (2013) G. H. Lyman et al. ONCOLOGIST
- Incidence and predictors of venous thromboembolism (VTE) among ambulatory high-risk cancer patients undergoing chemotherapy in the United States
- (2012) Alok A. Khorana et al. CANCER
- Perioperative Management of Antithrombotic Therapy
- (2012) James D. Douketis et al. CHEST
- A modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the Protecht score
- (2012) Melina Verso et al. Internal and Emergency Medicine
- Prediction of venous thromboembolism in cancer patients
- (2010) C. Ay et al. BLOOD
- Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial
- (2010) Michael Rud Lassen et al. LANCET
- Low-Molecular-Weight Heparin vs Unfractionated Heparin for Perioperative Thromboprophylaxis in Patients With CancerA Systematic Review and Meta-analysis
- (2008) Elie A. Akl ARCHIVES OF INTERNAL MEDICINE
- Development and validation of a predictive model for chemotherapy-associated thrombosis
- (2008) A. A. Khorana et al. BLOOD
- GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
- (2008) Gordon H Guyatt et al. BMJ-British Medical Journal
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now